BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17052187)

  • 1. The aggravating role of the ubiquitin-proteasome system in neurodegenerative disease.
    Hung CC; Davison EJ; Robinson PA; Ardley HC
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):743-5. PubMed ID: 17052187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
    Ardley HC; Hung CC; Robinson PA
    FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Moore DJ; Dawson VL; Dawson TM
    Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome system and neurodegenerative disorders.
    Layfield R; Lowe J; Bedford L
    Essays Biochem; 2005; 41():157-71. PubMed ID: 16250904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute polyglutamine expression in inducible mouse model unravels ubiquitin/proteasome system impairment and permanent recovery attributable to aggregate formation.
    Ortega Z; Díaz-Hernández M; Maynard CJ; Hernández F; Dantuma NP; Lucas JJ
    J Neurosci; 2010 Mar; 30(10):3675-88. PubMed ID: 20220001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW; McNaught KS
    Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
    Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
    Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
    Huang Q; Figueiredo-Pereira ME
    Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
    Tank EM; True HL
    PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components.
    Stenoien DL; Mielke M; Mancini MA
    Nat Cell Biol; 2002 Oct; 4(10):806-10. PubMed ID: 12360291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
    Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
    Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.
    Bedford L; Hay D; Devoy A; Paine S; Powe DG; Seth R; Gray T; Topham I; Fone K; Rezvani N; Mee M; Soane T; Layfield R; Sheppard PW; Ebendal T; Usoskin D; Lowe J; Mayer RJ
    J Neurosci; 2008 Aug; 28(33):8189-98. PubMed ID: 18701681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.